Position in RXST
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$248,712
+$187,112 QoQ
Shares Held
51,600
+416.0% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#66
of 150 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RXST Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $16,970,515 across 13 Medical Devices names. RXST ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
36,381 | $11,487,300 | |
| 2 | AVNS |
Avanos Medical, Inc.
|
115,133 | $2,864,509 | |
| 3 | BIO |
Bio-Rad Laboratories, Inc.
|
2,015 | $591,624 | |
| 4 | TNDM |
Tandem Diabetes Care Inc
|
19,002 | $286,740 | |
| 5 | DXCM |
Dexcom Inc
|
3,857 | $259,768 | |
| 6 | RXST |
RxSight, Inc.
This page
|
51,600 | $248,712 | |
| 7 | BVS |
Bioventus Inc.
|
25,780 | $243,363 | |
| 8 | VREX |
Varex Imaging Corp
|
23,254 | $242,539 |
All Filings in RXST
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $248,712 | 51,600 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $61,600 | 10,000 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||